Editing the epigenome: technologies for programmable transcription and epigenetic modulation.
about
Genome-editing Technologies for Gene and Cell TherapyCRISPR-Mediated Epigenome EditingEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityCRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome EditingEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillLigand-binding domains of nuclear receptors facilitate tight control of split CRISPR activityStabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.Acoustic-transfection for genomic manipulation of single-cells using high frequency ultrasoundTALEored Epigenetics: A DNA-Binding Scaffold for Programmable Epigenome Editing and Analysis.Diversity and evolution of class 2 CRISPR-Cas systems.CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.Comparison of Cas9 activators in multiple species.ORChestrating the human DNA replication program.DNA replication origins-where do we begin?Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic EditingResearch Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative DermatologyLoss-of-function genetic tools for animal models: cross-species and cross-platform differences.Advanced Gene Manipulation Methods for Stem Cell Theranostics.CRISPR Editing in Biological and Biomedical Investigation.Epigenome profiling and editing of neocortical progenitor cells during development.Advances in the delivery of RNA therapeutics: from concept to clinical reality.Artificial Induction of Native Aquaporin-1 Expression in Human Salivary Cells.Targeted epigenetic editing of SPDEF reduces mucus production in lung epithelial cells.Epigenetics and allergy: from basic mechanisms to clinical applications.Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects.CRISPR: express delivery to any DNA address.CRISPR-Cas9 technology: applications and human disease modelling.Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.Epigenetic Regulation of the Thermogenic Adipose Program.Dysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes.The genetics revolution in rheumatology: large scale genomic arrays and genetic mapping.Is cellular heterogeneity merely a confounder to be removed from epigenome-wide association studies?Targeted Epigenetic Remodeling of Endogenous Loci by CRISPR/Cas9-Based Transcriptional Activators Directly Converts Fibroblasts to Neuronal Cells.Open chromatin profiling as a novel strategy for identifying cancer cell of origin.Rapid and reversible epigenome editing by endogenous chromatin regulatorsRegulation of cancer epigenomes with a histone-binding synthetic transcription factor.Genome engineering: a new approach to gene therapy for neuromuscular disorders.Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDACERK-Induced Activation of TCF Family of SRF Cofactors Initiates a Chromatin Modification Cascade Associated with Transcription
P2860
Q26769662-BBD3A663-29D0-4622-B3B0-C8C7B06B584DQ28075872-2DDB3C56-B789-4414-B5BD-6F95C6AD8618Q28075883-6473B50A-F914-4CF7-B8BA-EAAE5084923EQ28079519-6BE9927E-B5F4-4259-803B-E9A275B4C09DQ28080188-A2BD4EDA-44C5-43FF-B986-8EA9A56AA353Q28831343-C6A7DC43-B68C-4EE3-A50B-9F4FDF3CFAFFQ30356570-C7E9D35C-8FB0-41B8-8AC8-D552E562B0B4Q33903140-26EF387C-3394-42F6-BDB8-74737FA764D2Q35955504-F4FBAC67-0B11-40D3-BB65-39B8A415BB3FQ36256836-FD37EB46-1C18-41A6-AFC2-7F03FCA0E1B8Q36331722-2FFCCEDA-9923-4EE9-A666-F525AD4C4E10Q37052928-BFCCE501-8517-4245-806E-23728330DBF5Q37199965-28B075A8-E4B5-4119-BBA2-12CDFB05D70AQ37212976-6BFB6029-FC49-4100-AAC0-FFDE1F827D6AQ37289829-1004877F-EE63-4C8A-B9B1-7189BCC07F37Q37296320-05DB3A79-B859-4D5D-82B4-5D815DF44C1EQ37550614-EAC6E07D-00C9-429D-9CC7-44C9B6CF39B6Q38287471-3E382B43-27B3-4941-9E57-A994A768BF96Q38645581-A75E171C-C431-47E6-8060-BF8A336B6DF5Q38648105-1FC01023-63E2-4485-958D-0E10C01989B8Q38706445-0AB97C7F-969F-4B12-BCCC-4E28C078CFACQ38722099-BDD705A0-70BD-477B-BB94-4646C5F338B0Q38724563-DA7BE376-4A2E-4749-836C-240912ADC3E6Q38742430-4335C538-7D6D-4845-8308-4FC6A6DAACCEQ38791734-69E9D9E6-DA8C-4287-B83A-0F1FE02E9BC9Q38797121-B036A961-722E-4BA2-B939-010191CDBE15Q38848400-FE7B7AEA-D675-49A6-BEAD-7AB18B27205CQ38916715-4C97935F-CFB2-42CA-B3A1-82F4F970C396Q38969422-3DD2F81F-57F0-4C65-9F1A-B8588D82CCFEQ38975402-FC1DCB2A-381D-41CE-B2BD-86ED8AC71A1DQ39014648-A0B5A860-FD14-480D-8320-0511310DC704Q39343367-C02D7F57-D954-4E35-9001-84E010670393Q40106251-DEE62049-9344-4A2C-A737-E9D2B640B32AQ40622309-2E067B66-574F-49F9-A19C-F970E70965B6Q41662160-7903E271-B169-4BA5-A854-DA7BB6FD7AA7Q41701373-C1D6B8E4-ECE7-4371-9C1D-05FD2E2DA497Q41734326-308CFBC3-25AC-42E9-AD9E-DAE2437139C0Q41928233-84E6215B-4E2D-4474-B036-98853F449C76Q41950227-99B278E7-C98E-4713-9E37-6A8B6902E0E0Q41977715-422DD53C-F891-4EFE-922B-C0B4341AD402
P2860
Editing the epigenome: technologies for programmable transcription and epigenetic modulation.
description
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Editing the epigenome: technol ...... ion and epigenetic modulation.
@en
Editing the epigenome: technol ...... ion and epigenetic modulation.
@nl
type
label
Editing the epigenome: technol ...... ion and epigenetic modulation.
@en
Editing the epigenome: technol ...... ion and epigenetic modulation.
@nl
prefLabel
Editing the epigenome: technol ...... ion and epigenetic modulation.
@en
Editing the epigenome: technol ...... ion and epigenetic modulation.
@nl
P2093
P2860
P356
P1433
P1476
Editing the epigenome: technol ...... ion and epigenetic modulation.
@en
P2093
Charles A Gersbach
Isaac B Hilton
Joshua B Black
Pratiksha I Thakore
P2860
P2888
P304
P356
10.1038/NMETH.3733
P577
2016-01-01T00:00:00Z